comScore is a global information and analytics company that measures consumer audiences and advertising across media platforms. The company creates its products using a global data platform that combines information about content and advertising consumption on digital platforms (smartphones, tablets and computers), television and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. The company provides audience ratings, advertising verification, and granular consumer segments that describe consumers.

First Financial Bankshares is a financial holding company. Through its subsidiaries, the company conducts commercial banking business. The company's banking centers are located primarily in Central, North Central, Southeast and West Texas. Each of the company's bank regions provides general commercial banking services, which include accepting and holding checking, savings and time deposits, making loans, automated teller machines, drive-in and night deposit services, safe deposit facilities, remote deposit capture, internet banking, mobile banking, payroll cards, transmitting funds, and performing other customary commercial banking services.

RumbleON is a development stage company. The company is engaged in developing a capital light e-commerce platform facilitating the ability of both consumers and dealers to Buy-Sell-Trade-Finance pre-owned recreation vehicles in one online location. Serving both consumers and dealers, through its online marketplace platform, the company makes cash offers for the purchase of pre-owned vehicles. In addition, the company provides an inventory of pre-owned vehicles for sale along with third-party financing and associated products. The company utilizes regional partners in the acquisition of pre-owned vehicles to provide inspection, reconditioning and distribution services.

ZIOPHARM Oncology is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing immuno-oncology platforms that utilize cell- and gene-based therapies to treat patients with cancer. The company is developing immuno-oncology platform technologies for the treatment of various cancer types. The company's Sleeping Beauty platform is based on the genetic engineering of immune cells using a non-viral transposon/transposase system to reprogram T cells outside of the body for subsequent infusion. The company's Controlled IL-12 platform is designed to stimulate expression of interleukin 12, a regulator of the immune system to focus the patient's immune system to attack cancer cells.